aluates Reports

$ 0.0

Automative

Global Canagliflozin Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-18P8068

Global Canagliflozin Market Insights Forecast to 2028

BUY CHAPTERS

Global Canagliflozin Market Research Report 2025

Code: QYRE-Auto-18P8068

Report

July 2025

Pages:73

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Janssen Pharmaceuticals

Mitsubishi Tanabe Pharma

Hansoh Pharma

Hinye

Canagliflozin Market

The global market for Canagliflozin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Canagliflozin is an oral diabetes medicine that helps control blood sugar levels.

Canagliflozin works by helping the kidneys get rid of glucose from your bloodstream. Canagliflozin is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Canagliflozin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Canagliflozin.

The Canagliflozin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Canagliflozin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Canagliflozin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Canagliflozin Market Report

Report Metric	Details
Report Name	Canagliflozin Market
Segment by Type	100mg 300mg
Segment by Application	Diabetes Heart Disease Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Janssen Pharmaceuticals, Mitsubishi Tanabe Pharma, Hansoh Pharma, Hinye
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Canagliflozin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Canagliflozin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Canagliflozin Market report?

Ans: The main players in the Canagliflozin Market are Janssen Pharmaceuticals, Mitsubishi Tanabe Pharma, Hansoh Pharma, Hinye

What are the Application segmentation covered in the Canagliflozin Market report?

Ans: The Applications covered in the Canagliflozin Market report are Diabetes, Heart Disease, Others

What are the Type segmentation covered in the Canagliflozin Market report?

Ans: The Types covered in the Canagliflozin Market report are 100mg, 300mg

1 Canagliflozin Market Overview

1.1 Product Definition

1.2 Canagliflozin by Type

1.2.1 Global Canagliflozin Market Value Comparison by Type (2024 VS 2031)

1.2.2 100mg

1.2.3 300mg

1.3 Canagliflozin by Application

1.3.1 Global Canagliflozin Market Value by Application (2024 VS 2031)

1.3.2 Diabetes

1.3.3 Heart Disease

1.3.4 Others

1.4 Global Canagliflozin Market Size Estimates and Forecasts

1.4.1 Global Canagliflozin Revenue 2020-2031

1.4.2 Global Canagliflozin Sales 2020-2031

1.4.3 Global Canagliflozin Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Canagliflozin Market Competition by Manufacturers

2.1 Global Canagliflozin Sales Market Share by Manufacturers (2020-2025)

2.2 Global Canagliflozin Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Canagliflozin Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Canagliflozin, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Canagliflozin, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Canagliflozin, Product Type & Application

2.7 Global Key Manufacturers of Canagliflozin, Date of Enter into This Industry

2.8 Global Canagliflozin Market Competitive Situation and Trends

2.8.1 Global Canagliflozin Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Canagliflozin Players Market Share by Revenue

2.8.3 Global Canagliflozin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Canagliflozin Market Scenario by Region

3.1 Global Canagliflozin Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Canagliflozin Sales by Region: 2020-2031

3.2.1 Global Canagliflozin Sales by Region: 2020-2025

3.2.2 Global Canagliflozin Sales by Region: 2026-2031

3.3 Global Canagliflozin Revenue by Region: 2020-2031

3.3.1 Global Canagliflozin Revenue by Region: 2020-2025

3.3.2 Global Canagliflozin Revenue by Region: 2026-2031

3.4 North America Canagliflozin Market Facts & Figures by Country

3.4.1 North America Canagliflozin Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Canagliflozin Sales by Country (2020-2031)

3.4.3 North America Canagliflozin Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Canagliflozin Market Facts & Figures by Country

3.5.1 Europe Canagliflozin Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Canagliflozin Sales by Country (2020-2031)

3.5.3 Europe Canagliflozin Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Canagliflozin Market Facts & Figures by Region

3.6.1 Asia Pacific Canagliflozin Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Canagliflozin Sales by Region (2020-2031)

3.6.3 Asia Pacific Canagliflozin Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Canagliflozin Market Facts & Figures by Country

3.7.1 Latin America Canagliflozin Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Canagliflozin Sales by Country (2020-2031)

3.7.3 Latin America Canagliflozin Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Canagliflozin Market Facts & Figures by Country

3.8.1 Middle East and Africa Canagliflozin Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Canagliflozin Sales by Country (2020-2031)

3.8.3 Middle East and Africa Canagliflozin Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Canagliflozin Sales by Type (2020-2031)

4.1.1 Global Canagliflozin Sales by Type (2020-2025)

4.1.2 Global Canagliflozin Sales by Type (2026-2031)

4.1.3 Global Canagliflozin Sales Market Share by Type (2020-2031)

4.2 Global Canagliflozin Revenue by Type (2020-2031)

4.2.1 Global Canagliflozin Revenue by Type (2020-2025)

4.2.2 Global Canagliflozin Revenue by Type (2026-2031)

4.2.3 Global Canagliflozin Revenue Market Share by Type (2020-2031)

4.3 Global Canagliflozin Price by Type (2020-2031)

5 Segment by Application

5.1 Global Canagliflozin Sales by Application (2020-2031)

5.1.1 Global Canagliflozin Sales by Application (2020-2025)

5.1.2 Global Canagliflozin Sales by Application (2026-2031)

5.1.3 Global Canagliflozin Sales Market Share by Application (2020-2031)

5.2 Global Canagliflozin Revenue by Application (2020-2031)

5.2.1 Global Canagliflozin Revenue by Application (2020-2025)

5.2.2 Global Canagliflozin Revenue by Application (2026-2031)

5.2.3 Global Canagliflozin Revenue Market Share by Application (2020-2031)

5.3 Global Canagliflozin Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Janssen Pharmaceuticals

6.1.1 Janssen Pharmaceuticals Company Information

6.1.2 Janssen Pharmaceuticals Description and Business Overview

6.1.3 Janssen Pharmaceuticals Canagliflozin Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Janssen Pharmaceuticals Canagliflozin Product Portfolio

6.1.5 Janssen Pharmaceuticals Recent Developments/Updates

6.2 Mitsubishi Tanabe Pharma

6.2.1 Mitsubishi Tanabe Pharma Company Information

6.2.2 Mitsubishi Tanabe Pharma Description and Business Overview

6.2.3 Mitsubishi Tanabe Pharma Canagliflozin Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Mitsubishi Tanabe Pharma Canagliflozin Product Portfolio

6.2.5 Mitsubishi Tanabe Pharma Recent Developments/Updates

6.3 Hansoh Pharma

6.3.1 Hansoh Pharma Company Information

6.3.2 Hansoh Pharma Description and Business Overview

6.3.3 Hansoh Pharma Canagliflozin Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Hansoh Pharma Canagliflozin Product Portfolio

6.3.5 Hansoh Pharma Recent Developments/Updates

6.4 Hinye

6.4.1 Hinye Company Information

6.4.2 Hinye Description and Business Overview

6.4.3 Hinye Canagliflozin Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Hinye Canagliflozin Product Portfolio

6.4.5 Hinye Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Canagliflozin Industry Chain Analysis

7.2 Canagliflozin Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Canagliflozin Production Mode & Process Analysis

7.4 Canagliflozin Sales and Marketing

7.4.1 Canagliflozin Sales Channels

7.4.2 Canagliflozin Distributors

7.5 Canagliflozin Customer Analysis

8 Canagliflozin Market Dynamics

8.1 Canagliflozin Industry Trends

8.2 Canagliflozin Market Drivers

8.3 Canagliflozin Market Challenges

8.4 Canagliflozin Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Janssen Pharmaceuticals

Mitsubishi Tanabe Pharma

Hansoh Pharma

Hinye

List of Tables

Table 1. Global Canagliflozin Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Canagliflozin Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Canagliflozin Market Competitive Situation by Manufacturers in 2024

Table 4. Global Canagliflozin Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Canagliflozin Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Canagliflozin Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Canagliflozin Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Canagliflozin Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Canagliflozin, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Canagliflozin, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Canagliflozin, Product Type & Application

Table 12. Global Key Manufacturers of Canagliflozin, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Canagliflozin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Canagliflozin as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Canagliflozin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Canagliflozin Sales by Region (2020-2025) & (K Units)

Table 18. Global Canagliflozin Sales Market Share by Region (2020-2025)

Table 19. Global Canagliflozin Sales by Region (2026-2031) & (K Units)

Table 20. Global Canagliflozin Sales Market Share by Region (2026-2031)

Table 21. Global Canagliflozin Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Canagliflozin Revenue Market Share by Region (2020-2025)

Table 23. Global Canagliflozin Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Canagliflozin Revenue Market Share by Region (2026-2031)

Table 25. North America Canagliflozin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Canagliflozin Sales by Country (2020-2025) & (K Units)

Table 27. North America Canagliflozin Sales by Country (2026-2031) & (K Units)

Table 28. North America Canagliflozin Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Canagliflozin Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Canagliflozin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Canagliflozin Sales by Country (2020-2025) & (K Units)

Table 32. Europe Canagliflozin Sales by Country (2026-2031) & (K Units)

Table 33. Europe Canagliflozin Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Canagliflozin Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Canagliflozin Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Canagliflozin Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Canagliflozin Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Canagliflozin Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Canagliflozin Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Canagliflozin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Canagliflozin Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Canagliflozin Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Canagliflozin Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Canagliflozin Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Canagliflozin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Canagliflozin Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Canagliflozin Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Canagliflozin Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Canagliflozin Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Canagliflozin Sales (K Units) by Type (2020-2025)

Table 51. Global Canagliflozin Sales (K Units) by Type (2026-2031)

Table 52. Global Canagliflozin Sales Market Share by Type (2020-2025)

Table 53. Global Canagliflozin Sales Market Share by Type (2026-2031)

Table 54. Global Canagliflozin Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Canagliflozin Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Canagliflozin Revenue Market Share by Type (2020-2025)

Table 57. Global Canagliflozin Revenue Market Share by Type (2026-2031)

Table 58. Global Canagliflozin Price (US$/Unit) by Type (2020-2025)

Table 59. Global Canagliflozin Price (US$/Unit) by Type (2026-2031)

Table 60. Global Canagliflozin Sales (K Units) by Application (2020-2025)

Table 61. Global Canagliflozin Sales (K Units) by Application (2026-2031)

Table 62. Global Canagliflozin Sales Market Share by Application (2020-2025)

Table 63. Global Canagliflozin Sales Market Share by Application (2026-2031)

Table 64. Global Canagliflozin Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Canagliflozin Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Canagliflozin Revenue Market Share by Application (2020-2025)

Table 67. Global Canagliflozin Revenue Market Share by Application (2026-2031)

Table 68. Global Canagliflozin Price (US$/Unit) by Application (2020-2025)

Table 69. Global Canagliflozin Price (US$/Unit) by Application (2026-2031)

Table 70. Janssen Pharmaceuticals Company Information

Table 71. Janssen Pharmaceuticals Description and Business Overview

Table 72. Janssen Pharmaceuticals Canagliflozin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Janssen Pharmaceuticals Canagliflozin Product

Table 74. Janssen Pharmaceuticals Recent Developments/Updates

Table 75. Mitsubishi Tanabe Pharma Company Information

Table 76. Mitsubishi Tanabe Pharma Description and Business Overview

Table 77. Mitsubishi Tanabe Pharma Canagliflozin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Mitsubishi Tanabe Pharma Canagliflozin Product

Table 79. Mitsubishi Tanabe Pharma Recent Developments/Updates

Table 80. Hansoh Pharma Company Information

Table 81. Hansoh Pharma Description and Business Overview

Table 82. Hansoh Pharma Canagliflozin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Hansoh Pharma Canagliflozin Product

Table 84. Hansoh Pharma Recent Developments/Updates

Table 85. Hinye Company Information

Table 86. Hinye Description and Business Overview

Table 87. Hinye Canagliflozin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Hinye Canagliflozin Product

Table 89. Hinye Recent Developments/Updates

Table 90. Key Raw Materials Lists

Table 91. Raw Materials Key Suppliers Lists

Table 92. Canagliflozin Distributors List

Table 93. Canagliflozin Customers List

Table 94. Canagliflozin Market Trends

Table 95. Canagliflozin Market Drivers

Table 96. Canagliflozin Market Challenges

Table 97. Canagliflozin Market Restraints

Table 98. Research Programs/Design for This Report

Table 99. Key Data Information from Secondary Sources

Table 100. Key Data Information from Primary Sources

Table 101. Authors List of This Report

List of Figures

Figure 1. Product Picture of Canagliflozin

Figure 2. Global Canagliflozin Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Canagliflozin Market Share by Type: 2024 & 2031

Figure 4. 100mg Product Picture

Figure 5. 300mg Product Picture

Figure 6. Global Canagliflozin Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Canagliflozin Market Share by Application: 2024 & 2031

Figure 8. Diabetes

Figure 9. Heart Disease

Figure 10. Others

Figure 11. Global Canagliflozin Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Canagliflozin Market Size (2020-2031) & (US$ Million)

Figure 13. Global Canagliflozin Sales (2020-2031) & (K Units)

Figure 14. Global Canagliflozin Average Price (US$/Unit) & (2020-2031)

Figure 15. Canagliflozin Report Years Considered

Figure 16. Canagliflozin Sales Share by Manufacturers in 2024

Figure 17. Global Canagliflozin Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Canagliflozin Players: Market Share by Revenue in Canagliflozin in 2024

Figure 19. Canagliflozin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Canagliflozin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Canagliflozin Sales Market Share by Country (2020-2031)

Figure 22. North America Canagliflozin Revenue Market Share by Country (2020-2031)

Figure 23. United States Canagliflozin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Canagliflozin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Canagliflozin Sales Market Share by Country (2020-2031)

Figure 26. Europe Canagliflozin Revenue Market Share by Country (2020-2031)

Figure 27. Germany Canagliflozin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Canagliflozin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Canagliflozin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Canagliflozin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Canagliflozin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Canagliflozin Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Canagliflozin Revenue Market Share by Region (2020-2031)

Figure 34. China Canagliflozin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Canagliflozin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Canagliflozin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Canagliflozin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Canagliflozin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan Canagliflozin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Indonesia Canagliflozin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Thailand Canagliflozin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Malaysia Canagliflozin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Latin America Canagliflozin Sales Market Share by Country (2020-2031)

Figure 44. Latin America Canagliflozin Revenue Market Share by Country (2020-2031)

Figure 45. Mexico Canagliflozin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Brazil Canagliflozin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Argentina Canagliflozin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Canagliflozin Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Canagliflozin Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Canagliflozin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Canagliflozin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE Canagliflozin Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Canagliflozin by Type (2020-2031)

Figure 54. Global Revenue Market Share of Canagliflozin by Type (2020-2031)

Figure 55. Global Canagliflozin Price (US$/Unit) by Type (2020-2031)

Figure 56. Global Sales Market Share of Canagliflozin by Application (2020-2031)

Figure 57. Global Revenue Market Share of Canagliflozin by Application (2020-2031)

Figure 58. Global Canagliflozin Price (US$/Unit) by Application (2020-2031)

Figure 59. Canagliflozin Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Canagliflozin Hemihydrate Market Research Report 2024

Global Empagliflozin Tablets Market Research Report 2025

Global Luseogliflozin Market Research Report 2024

Global Empagliflozin API Market Research Report 2024

Oral Hypoglycemic Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Sotagliflozin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oral Medicines for Diabetes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oral Anti Diabetic Drug Market Insights Forecast to 2030

Global Tofogliflozin Market Research Report 2025

Dapagliflozin API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oral Blood Glucose Regulators Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Metformin Hydrochlorid Market Research Report 2024

Global SGLT2 Inhibitors Treatment Market Research Report 2024

Global Dapagliflozin Tablets Market Research Report 2024

Global Oral Antidiabetic Drugs Market Insights Forecast to 2030

Global SGLT 2 Inhibitors for Type 2 Diabetes Treatment Market Research Report 2025

Global Metformin Hydrochloride and Glipizide Tablets Market Research Report 2024

Global Diabetes Drugs Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Global Diabetes Oral Medicine Dorzagliatin Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions